期刊文献+

2010年中国CHINET血流感染的病原菌分布及耐药性 被引量:71

Bacterial distribution and susceptibility in bloodstream infections in China antibiotic resistance surveillance program CHINET 2010
下载PDF
导出
摘要 目的了解2010年CHINET血培养分离菌的菌种分布和耐药性。方法对CHINET细菌耐药监测网2010年1月至2010年12月所有血标本按常规方法进行细菌分离、培养、鉴定。按统一方案用K-B纸片扩散法进行抗菌药敏感试验。结果 2010年自血液标本中共获分离细菌5 646株,其中革兰阳性球菌占64.3%,革兰阴性杆菌占35.6%。最常见的分离菌分别为凝固酶阴性葡萄球菌(47.0%)、大肠埃希菌(1 5.0%)、肠球菌属细菌(7.4%)、克雷伯菌属细菌(6.0%)、金葡菌(5.6%)、不动杆菌属细菌(3.9%)、假单胞菌属细菌(2.9%)、草绿色链球菌(2.9%)、肠杆菌属细菌(1.9%)、沙门菌属细菌(1.2%)和嗜麦芽窄食单胞菌(1.1%),占分离菌株的94.8%。MRSA及MRCNS分别占金葡菌和凝固酶阴性葡萄球菌的51.1%和56.8%。粪肠球菌对高浓度庆大霉素和氨苄西林的耐药率分别为34.3%和14.7%,屎肠球菌对多数测试药物的耐药率显著高于粪肠球菌。草绿色链球菌对青霉素的耐药率为11.2%。葡萄球菌、肺炎链球菌和其他链球菌属细菌中均未发现万古霉素、替考拉宁和利奈唑胺耐药菌株,粪肠球菌和屎肠球菌对万古霉素的耐药率分别为2.1%和7.0%。大肠埃希菌、克雷伯菌属、肠杆菌属、沙雷菌属、变形菌属和枸橼酸菌属细菌等肠杆菌科细菌对亚胺培南、美罗培南的耐药率在0~10%,但克雷伯菌属、肠杆菌属、沙雷菌属和变形菌属细菌对厄他培南的耐药率达10%~20%。不发酵糖革兰阴性杆菌对碳青霉烯类抗生素耐药率较高,铜绿假单胞菌对碳青霉烯类抗生素的耐药率为18.3%~22%,但不动杆菌属细菌耐药率达57%。结论 2010年CHINET监测资料显示革兰阳性菌,尤其是CNS在血流感染中占重要地位,血培养分离株对常用抗菌药严重耐药,因此应合理应用抗菌药物,并加强医院感染控制措施以抑制耐药菌传播。 blood culture were routinely identified. The antimicrobial susceptibility to more than 20 antimicrobial agents was determined by Kirby-Bauer method in the participating institutions. Results A total of 5 646 strains were isolated from blood specimens in 2010. Gram positive cocci and Gram negative bacilli accounted for 64.3% and 35.60%, respectively. The most frequent isolates were coagulase-negative Staphylococcus (CNS) (47%), E. coli (15.1%), Enterococcus (7.4%), Klebsiella (6.0%), S. au- reus (5.6%), Acinetobacter (3. 9%), P. aeruginosa (2. 9%), S. viridans (2. 9%), Enterobacter ( 1. 9%), Salmonella (1.2%) and S. maltophilia (1. 1%), taken together accounting for 94.8% of all blood culture isolates. The prevalence of MRSA in S. aureus and MRCNS in coagulase-negative Staphylococcus was 51.1% and 56.8%, respectively. The percentage of gentamicin- or ampicillin-resistant E. faecium was 34.3% and 14.7%, respectively, significantly higher than that of E. faecalis. No strain was found resistant to vancomycin, teicoplanin or linezolid in Staphylococcus, Streptococcus or S. pneu- moniae. The prevalence of vancomycin-resistant strain was 2.1% in E. faecalis and 7.0% in E. faecium. Imipenem or mero- penem resistance was found in about 0-10% of the isolates in the Enterobacteriaceae species, including E. coli, Klebsiella, En- terobacter, Serratia, and Citrobacter. About 10% to 20% of the isolates were resistant to ertapenem in Klebsiella, Enter- obacter, Serratia, and Proteus species. Nonfermenters were highly resistant to carbapenems, especially Acinetobacter (57% resistant). Carbapenem resistance was found in 18.3% to 22% of P. aeruginosa isolates. Conclusions Gram positive coccus plays an important role in blood stream infections, especially CNS. The resistance to the first line antibiotics is common among all blood isolates. Antimicrobial agents should be used appropriately to reduce the selection pressure. Hospital infection control measures should be strengthened to prevent the spread of resistant organisms.
出处 《中国感染与化疗杂志》 CAS 北大核心 2012年第4期251-258,共8页 Chinese Journal of Infection and Chemotherapy
关键词 血培养 临床分离菌 敏感性 blood culture clinical isolate antimicrobial susceptibility
  • 相关文献

参考文献23

  • 1Diekema DJ, Beekmann SE, Chapin KC,et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infeetion[J]. J Clin Mierobiol, 2003,41(8) :3655-3660.
  • 2Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med, 2003, 348(16):1546-1554.
  • 3Reacher MH, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis[J]. Br Med J, 2000, 320(7299): 213-216.
  • 4Rodriguez-Creixems M, Alcald L, Mufioz P, et al. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006[J]. Medicine (Baltimore), 2008, 87(4) : 234-249.
  • 5American Society for Microbiology. Report of the ASM task force on antibiotic resistance [J].Antimicrob Agents Chemother, 1995, Suppl : 1-23.
  • 6Centers for Disease Control and Prevention. CDC's campaign to prevent antimicrobial resistance in health-care settings[J]. MMWR Morb Mortal Wkly Rep, 2002,51(15) :343.
  • 7Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997[J].Clin Infect Dis, 1999,29(3) :595-607.
  • 8Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections [J]. Clin Infect Dis, 2009, 48(Suppl 4) : S238-S245.
  • 9Rodriguez-Bafio J, de Cueto M, Retamar P, et al. Current management of bloodstream infections[J]. Expert Rev Anti Infect Ther, 2010, 8(7):815-829.
  • 10Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults[J]. Clin Infect Dis, 1997, 24(4) :584-502.

二级参考文献41

  • 1[1]Pittet D, Li N, Woolson RF,et al. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model[J]. Clin Infect Dis,1997,24 : 1068-1078
  • 2[2]Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults[J]. Clin Infect Dis, 1997, 24:584-602
  • 3[3]Karchmer AW. Nosocomial bloodstream infections: organisms,risk factors, and implications[J]. Clin Infect Dis, 2000, 31(Suppl 4) :S139-143
  • 4[4]Kim SD, McDonald LC, Jarvis WR, et al. Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community hospital: a role for species and strain identification[J]. Infect Control Hosp Epidemiol, 2000,21 :213-217
  • 5[5]Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults[J]. Clin Infect Dis, 1997,24: 584-602
  • 6上海第一医学院.败血症630例临床分析[J].江苏医药,1982,(8):589-292.
  • 7[8]Diekema DJ, Pfaller MA, Jones RN, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America[J]. Int J Antimicrob Agents, 2000, 13:257-271
  • 8[9]Edmond MB, Wallace SE, McClish DK, et al. Nosocomial bloodstream infections in United States hospitals : a hree-year analysis[J].Clin Infect Dis, 1999,29:239-244
  • 9[10]No authors listed. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999[J]. Am J Infect Control, 1999, 27:520-532
  • 10[13]Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia[J]. Clin Microbiol Rev. 1998,11: 57-80

共引文献582

同被引文献544

引证文献71

二级引证文献809

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部